Jiangsu Kangbeide Pharmaceutical

Jiangsu Kangbeide Pharmaceutical is a specialty pharmaceutical company headquartered in Nanjing, China, dedicated to the development and production of advanced transdermal drug delivery systems (TDDS). The company focuses on high-tech barrier patches and topical formulations for the treatment of central nervous system disorders and chronic pain. Its commercial portfolio includes Fentanyl and Rivastigmine patches, which utilize sophisticated controlled-release technology to improve patient compliance and therapeutic outcomes. Jiangsu Kangbeide maintains large-scale GMP manufacturing capabilities and is recognized as a leading player in the Chinese transdermal patch market. The company's R&D efforts are centered on overcoming the technical challenges of skin permeation and adhesive stability for complex molecules. By integrating research, production, and sales, Kangbeide aims to provide high-quality, affordable alternatives to imported transdermal products.